Cipla – Hot or Not

Cipla (NSE-India:CIPLA) is an Indian multinational pharmaceutical and biotechnology company, specializing in HIV Aids drugs and active pharmaceutical ingredient manufacture. It has a market cap of $7.0 billion, a PE of 45.3 and a dividend yield of 0.4 per cent. Guest Jean Pierre Verster from Fairtree Capital and resident expert Paul Theron from Vestact decide whether Cipla is hot or not.

Leave a Comment